Dr Reddys Laboratories Share Price Today - Live Blog for October 03, 2025

There was no change in the share price of Dr Reddys Laboratories Ltd, and it continues to trade at ₹1,248.00. The stock has a PE ratio of 18.3100, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

With a -0.10% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,246.50. The stock is currently trading at a PE of 18.3100, while the industry PE is 34.2890, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's stock has surged by 0.23%, and it is currently trading at ₹1,249.65. Additionally, the stock maintains a PE ratio of 18.3100, while the industry PE is 34.2890.

With a -0.08% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,247.25. The stock is currently trading at a PE of 18.3100, while the industry PE is 34.2890, prompting investors to assess its value proposition.

Demonstrating a commendable 0.52% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,248.20. In terms of valuation, the stock maintains a PE ratio of 18.3100, while the industry PE ratio stands at 34.2890.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.52% uptick in its share price. As a result, it's now actively trading at ₹1,248.20 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd share price surged by 0.52%. With its current market price standing at ₹1,248.20 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd experienced a -0.29% downturn in its share price, and it's currently trading at ₹1,240.80. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd experienced a -0.29% dip in its share price and is currently trading at ₹1,240.80. The stock has a PE ratio of 18.3100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.29% in its share price, and it currently trades at ₹1,240.80 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.20% in its share price, and it currently trades at ₹1,243.20 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

With a -0.21% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,245.95. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.3100, while the industry PE is 34.2890.

The stock of Dr Reddys Laboratories Ltd suffered a -0.22% decline, and it currently trades at ₹1,247.30 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

After a significant 0.04% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,250.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.06%, reaching a current market price of ₹1,249.50. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

After a significant 0.01% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,250.15 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd's shares experienced a 0.01% uptick, and they are currently valued at ₹1,250.15, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.02%. At this moment, it's actively trading at ₹1,250.15, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd share price has declined by -0.05%, and it's currently trading at ₹1,250.05. The stock maintains a PE of 18.3100, while the industry PE is 34.2890, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.18%, and as of now, it's trading at ₹1,249.15 per share. This upward trajectory is attracting keen interest from investors.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.05%. At this moment, it's actively trading at ₹1,247.20, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.05% upswing, and it's currently trading at ₹1,247.20 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd witnessed a notable 0.05% surge in its share price and is presently trading at ₹1,247.20, captivating the attention of market participants.

After a -0.19% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,245.55. The stock has a PE ratio of 18.3100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.02% downturn in its share price, and it's currently trading at ₹1,251.25. This situation is generating interest among value investors who are evaluating the stock's potential.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.27% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,251.60 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.04%, signalling a challenging period. Currently trading at ₹1,249.05, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd experienced a substantial 0.10% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,251.20, making it an appealing option for investors.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.06%, reaching the current market price of ₹1,244.75. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.